Skip to Content
Merck
CN

PAX1 is essential for development and function of the human thymus.

Science immunology (2020-03-01)
Yasuhiro Yamazaki, Raul Urrutia, Luis M Franco, Silvia Giliani, Kejian Zhang, Anas M Alazami, A Kerry Dobbs, Stefania Masneri, Avni Joshi, Francisco Otaizo-Carrasquero, Timothy G Myers, Sundar Ganesan, Maria Pia Bondioni, Mai Lan Ho, Catherine Marks, Huda Alajlan, Reem W Mohammed, Fanggeng Zou, C Alexander Valencia, Alexandra H Filipovich, Fabio Facchetti, Bertrand Boisson, Chiara Azzari, Bander K Al-Saud, Hamoud Al-Mousa, Jean Laurent Casanova, Roshini S Abraham, Luigi D Notarangelo
ABSTRACT

We investigated the molecular and cellular basis of severe combined immunodeficiency (SCID) in six patients with otofaciocervical syndrome type 2 who failed to attain T cell reconstitution after allogeneic hematopoietic stem cell transplantation, despite successful engraftment in three of them. We identified rare biallelic PAX1 rare variants in all patients. We demonstrated that these mutant PAX1 proteins have an altered conformation and flexibility of the paired box domain and reduced transcriptional activity. We generated patient-derived induced pluripotent stem cells and differentiated them into thymic epithelial progenitor cells and found that they have an altered transcriptional profile, including for genes involved in the development of the thymus and other tissues derived from pharyngeal pouches. These results identify biallelic, loss-of-function PAX1 mutations as the cause of a syndromic form of SCID due to altered thymus development.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-HA−TRITC antibody, Mouse monoclonal, ~1 mg/mL, clone HA-7, purified from hybridoma cell culture